IMAGE-BASED RADIATION THERAPY PLANNING FOR BRAIN TUMORS WITH F-18-FLUOROETHYLTYROSINE (FET) PET AND MRI: POTENTIAL IMPACT ON TARGET VOLUME DELINEATION

被引:0
|
作者
Pica, A.
Prior, J. O.
Maeder, P.
Paschoud, M.
Stupp, R.
Mirimanoff, R.
Delaloye, A. Bischof
Allenbach, G.
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1100 / 1100
页数:1
相关论文
共 31 条
  • [21] 11C-methionine-18F-FDG dual-PET-tracer-based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapy
    Hirata, Takero
    Kinoshita, Manabu
    Tamari, Keisuke
    Seo, Yuji
    Suzuki, Osamu
    Wakai, Nobuhide
    Achiha, Takamune
    Umehara, Toru
    Arita, Hideyuki
    Kagawa, Naoki
    Kanemura, Yonehiro
    Shimosegawa, Eku
    Hashimoto, Naoya
    Hatazawa, Jun
    Kishima, Haruhiko
    Teshima, Teruki
    Ogawa, Kazuhiko
    JOURNAL OF NEUROSURGERY, 2019, 131 (03) : 676 - 686
  • [22] Non-gated F-18 FDG PET/CT for target volume delineation in stereotactic body radiation therapy (SBRT) in patients with malignant lung lesions and clinical outcome
    Schmuecking, M.
    Klaeser, B.
    Toepfer, M.
    Malthaner, M.
    Frueh, M.
    Schmidhalter, D.
    Cihoric, N.
    Blumstein, N.
    Born, E.
    Plasswilm, L.
    Krause, T.
    Aebersold, D. M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 95 - 95
  • [23] Non-gated F-18 FDG PET/CT for target volume delineation in stereotactic body radiation therapy (SBRT) in patients with malignant lung lesions and clinical outcome
    Klass, N. D.
    Klaeser, B.
    Toepfer, M.
    Malthaner, M.
    Frueh, M.
    Schmidhalter, D.
    Cihoric, N.
    Born, E.
    Blumstein, N.
    Plasswilm, L.
    Krause, T.
    Aebersold, D. M.
    Schmuecking, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (08) : 742 - 743
  • [24] Radiation treatment planning in brain tumours Potential impact of 3-O-methyl-6-[18F]fluoro-L-DOPA and PET
    Alheit, H.
    Oehme, L.
    Winkler, C.
    Fuechtner, F.
    Hoepping, A.
    Grabowski, J.
    Kotzerke, I.
    Beuthien-Baumann, B.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2008, 47 (05): : 200 - 204
  • [25] USE OF SINGLE MRI AND 18F-FDG PET-CT SCANS IN BOTH DIAGNOSIS AND RADIOTHERAPY TREATMENT PLANNING IN PATIENTS WITH HEAD AND NECK CANCER: ADVANTAGE ON TARGET VOLUME AND CRITICAL ORGAN DELINEATION
    Gardner, Miriam
    Halimi, Philippe
    Valinta, Danielle
    Plantet, Marie-Madeleine
    Alberini, Jean-Louis
    Wartski, Myriam
    Banal, Alain
    Hans, Stephane
    Floiras, Jean-Louis
    Housset, Martin
    Labib, Alain
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2009, 31 (04): : 461 - 467
  • [26] Comparison of target volume definition for radiation therapy based on contrast-enhanced MRI, O-(2-(18F)-fluoroethyl)-L-tyrosine (FET)- and (68 Ga)-DOTA-D Phe 1-3Tyr3-Octreotide (DOTATOC)-PET in patients with meningiomas
    Dittmar, J. O.
    Giesel, F.
    Kratochwill, K.
    Christmann, A.
    Welzel, T.
    Habermehl, D.
    Rieken, S.
    Haberkorn, U.
    Debus, J.
    Combs, S. E.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 39 - 40
  • [27] 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY BASED RADIOTHERAPY TARGET VOLUME DEFINITION IN NON-SMALL-CELL LUNG CANCER: DELINEATION BY RADIATION ONCOLOGISTS VS. JOINT OUTLINING WITH A PET RADIOLOGIST?
    Hanna, Gerard G.
    Carson, Kathryn J.
    Lynch, Tom
    McAleese, Jonathan
    Cosgrove, Vivian P.
    Eakin, Ruth L.
    Stewart, David P.
    Zatari, Ashraf
    O'Sullivan, Joe M.
    Hounsell, Alan R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (04): : 1040 - 1051
  • [28] NON-GATED F-18 FDG PET/CT FOR TARGET VOLUME DELINEATION IN STEREOTACTIC BODY RADIATION THERAPY (SBRT) IN PATIENTS WITH STAGE I NON-SMALL CELL LUNG CANCER (NSCLC) OR HYPERMETABOLIC OLIGOMETASTATIC LUNG LESIONS
    Wolfensberger, P.
    Klaeser, B.
    Toepfer, M.
    Malthaner, M.
    Born, E.
    Schmuecking, M.
    Plasswilm, L.
    Aebersold, D. M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (08) : 535 - 535
  • [29] Non-gated F-18 FDG PET/CT for target volume delineation in stereotactic body radiation therapy (SBRT) in patients with stage I non-small cell lung cancer (NSCLC) or hypermetabolic oligometastatic lung lesions
    Schmuecking, M.
    Klaeser, B.
    Toepfer, M.
    Malthaner, M.
    Blumstein, N.
    Frueh, M.
    Born, E.
    Broemme, J.
    Plasswilm, L.
    Krause, T.
    Aebersold, D. M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 70 - 70
  • [30] NON-GATED F-18 FDG PET/CT FOR TARGET VOLUME DELINEATION IN STEREOTACTIC BODY RADIATION THERAPY (SBRT) IN PATIENTS WITH STAGE I NON-SMALL CELL LUNG CANCER (NSCLC) OR HYPERMETABOLIC OLIGOMETASTATIC LUNG LESIONS
    Schmuecking, M.
    Klaeser, B.
    Toepfer, M.
    Malthaner, M.
    Blumstein, N.
    Frueh, M.
    Born, E.
    Bromme, J. O.
    Plasswilm, L.
    Krause, T.
    Aebersold, D. M.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S343 - S344